{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T05:36:59Z","timestamp":1774330619456,"version":"3.50.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1093\/ecco-jcc\/jjx080","type":"journal-article","created":{"date-parts":[[2017,6,3]],"date-time":"2017-06-03T19:07:36Z","timestamp":1496516856000},"page":"1223-1229","source":"Crossref","is-referenced-by-count":15,"title":["Serial Tuberculosis Screening in Inflammatory Bowel Disease Patients Receiving Anti-TNF\u03b1 Therapy"],"prefix":"10.1093","volume":"11","author":[{"given":"C\u00e2ndida","family":"Abreu","sequence":"first","affiliation":[]},{"given":"Joana","family":"Afonso","sequence":"additional","affiliation":[]},{"given":"Cl\u00e1udia","family":"Camila Dias","sequence":"additional","affiliation":[]},{"given":"Rog\u00e9rio","family":"Ruas","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Sarmento","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Magro","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2017,6,9]]},"reference":[{"key":"key\n\t\t\t\t20170927205645_CIT0001","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/cid\/ciu796","article-title":"Prevention of anti-tumor necrosis factor-associated tuberculosis: a 10-year longitudinal cohort study","volume":"60","author":"Prevention of Anti-TNF\u2013Associated Tuberculosis Study Team of Bellvitge University Hospital","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170927205645_CIT0002","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1016\/j.crohns.2013.03.004","article-title":"Tuberculosis in anti-TNF-\u03b1 treated patients remains a problem in countries with an intermediate incidence: analysis of 25 patients matched with a control population","volume":"7","year":"2013","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t20170927205645_CIT0003","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement","volume":"36","year":"2010","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20170927205645_CIT0004","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","article-title":"Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists","volume":"52","author":"BIOBADASER Group","year":"2005","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170927205645_CIT0005","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.22768","article-title":"Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection","volume":"57","author":"Biobadaser Group","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170927205645_CIT0006","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ibd.21427","article-title":"Factors impacting the results of interferon-\u03b3 release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases","volume":"17","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20170927205645_CIT0007","first-page":"111","article-title":"Quantiferon TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents","volume":"31","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"key\n\t\t\t\t20170927205645_CIT0008","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3109\/00365521.2015.1064470","article-title":"The impact of immunosuppressive therapy on QuantiFERON and tuberculin skin test for screening of latent tuberculosis in patients with inflammatory bowel disease scheduled for anti-TNF therapy","volume":"50","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"key\n\t\t\t\t20170927205645_CIT0009","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/acr.21788","article-title":"Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trials","volume":"65","year":"2013","journal-title":"Arthritis Care Res [Hoboken]"},{"key":"key\n\t\t\t\t20170927205645_CIT0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5217\/ir.2014.12.1.12","article-title":"Diagnosis and treatment of latent tuberculosis infection in patients with inflammatory bowel diseases due to initiation of anti-tumor necrosis factor therapy","volume":"12","year":"2014","journal-title":"Intest Res"},{"key":"key\n\t\t\t\t20170927205645_CIT0011","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3899\/jrheum.090150","article-title":"Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial","volume":"36","year":"2009","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170927205645_CIT0012","doi-asserted-by":"crossref","first-page":"e0141033","DOI":"10.1371\/journal.pone.0141033","article-title":"The significance of sensitive interferon gamma release assays for diagnosis of latent tuberculosis infection in patients receiving tumor necrosis factor-\u03b1 antagonist therapy","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170927205645_CIT0013","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1164\/ajrccm.159.1.9801120","article-title":"Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion","volume":"159","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170927205645_CIT0014","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","article-title":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"European Crohn\u2019s and Colitis Organisation [ECCO]","year":"2014","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t20170927205645_CIT0015","first-page":"CD007545","article-title":"Rifamycins [rifampicin, rifabutin and rifapentine] compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20170927205645_CIT0016","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s10067-014-2669-0","article-title":"The role of interferon-gamma release assays in predicting the emergence of active tuberculosis in the setting of biological treatment: a case report and review of the literature","volume":"35","year":"2016","journal-title":"Clin Rheumatol"},{"key":"key\n\t\t\t\t20170927205645_CIT0017","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1136\/annrheumdis-2014-205376","article-title":"Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases","volume":"74","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170927205645_CIT0018","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.dld.2016.06.038","article-title":"An increase in serum tumour necrosis factor-\u03b1 during anti-tumour necrosis factor-\u03b1 therapy for Crohn\u2019s disease\u2014A paradox or a predictive index?","volume":"48","year":"2016","journal-title":"Dig Liver Dis"},{"key":"key\n\t\t\t\t20170927205645_CIT0019","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10067-016-3462-z","article-title":"The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis","volume":"36","year":"2017","journal-title":"Clin Rheumatol"},{"key":"key\n\t\t\t\t20170927205645_CIT0020","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1081-1206(10)62279-X","article-title":"Gender differences in response to the multitest CMI skin test in the general population","volume":"84","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"key\n\t\t\t\t20170927205645_CIT0021","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1164\/ajrccm.149.6.8004319","article-title":"Boosting of tuberculin sensitivity among Southeast Asian refugees","volume":"149","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20170927205645_CIT0022","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.trstmh.2005.03.001","article-title":"Tuberculin reactivity in adults after 50 years of universal Bacille Calmette-Guerin vaccination in Taiwan","volume":"99","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20170927205645_CIT0023","volume-title":"National Institute for Health and Care Excellence. Clinical Guidelines. Tuberculosis: Prevention, Diagnosis, Management and Service Organisation","year":"2016"},{"key":"key\n\t\t\t\t20170927205645_CIT0024","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20170927205645_CIT0025","doi-asserted-by":"crossref","first-page":"e8517","DOI":"10.1371\/journal.pone.0008517","article-title":"Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review","volume":"4","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170927205645_CIT0026","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/thx.2005.049759","article-title":"Repeated tuberculin testing does not induce false positive ELISPOT results","volume":"61","year":"2006","journal-title":"Thorax"},{"key":"key\n\t\t\t\t20170927205645_CIT0027","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010","volume":"59","author":"IGRA Expert Committee; Centers for Disease Control and Prevention [CDC]","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20170927205645_CIT0028","first-page":"49","article-title":"Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States","volume":"54","author":"Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention [CDC]","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20170927205645_CIT0029","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/thoraxjnl-2015-207811","article-title":"Effect of immunosuppressive therapy on interferon \u03b3 release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis","volume":"71","year":"2016","journal-title":"Thorax"},{"key":"key\n\t\t\t\t20170927205645_CIT0030","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s10067-012-2049-6","article-title":"Serial interferon-\u03b3 release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents","volume":"31","year":"2012","journal-title":"Clin Rheumatol"},{"key":"key\n\t\t\t\t20170927205645_CIT0031","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00420-010-0571-x","article-title":"Serial testing with the interferon-\u03b3 release assay in Portuguese healthcare workers","volume":"84","year":"2011","journal-title":"Int Arch Occup Environ Health"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/11\/10\/1223\/20220644\/jjx080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T00:56:58Z","timestamp":1506560218000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article\/11\/10\/1223\/3865746\/Serial-Tuberculosis-Screening-in-Inflammatory"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,9]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,6,9]]},"published-print":{"date-parts":[[2017,10]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx080","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,9]]}}}